DongBang Medical Co Ltd
KOSDAQ:240550
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
DongBang Medical Co Ltd
Net Income (Common)
DongBang Medical Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
DongBang Medical Co Ltd
KOSDAQ:240550
|
Net Income (Common)
₩11.7B
|
CAGR 3-Years
54%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Net Income (Common)
₩43.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
7%
|
|
|
SD Biosensor Inc
KRX:137310
|
Net Income (Common)
-₩98.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Net Income (Common)
₩14.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Net Income (Common)
-₩220.5B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Net Income (Common)
₩46.4B
|
CAGR 3-Years
33%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
DongBang Medical Co Ltd
Glance View
Dongbang Medical Co., Ltd. engages in the manufacturing and sale of oriental and aesthetic medical devices. The company is headquartered in Boryeong, Chungcheongnam-Do. The company went IPO on 2025-02-13. The firm operates its business through two segments. The Cosmetic Medical Devices segment is mainly engaged in the manufacture and sales of hyaluronic acid dermal filler, cannulas, thread and needles. The Oriental Medical Devices segment is mainly engaged in the production of sterrile acupuncture needles for single use and air extraction cupping device. In addition, the Company also provides mask pads, face cream and serum, clean wash, shampoo and treatment.
See Also
What is DongBang Medical Co Ltd's Net Income (Common)?
Net Income (Common)
11.7B
KRW
Based on the financial report for Dec 31, 2025, DongBang Medical Co Ltd's Net Income (Common) amounts to 11.7B KRW.
What is DongBang Medical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
54%
Over the last year, the Net Income (Common) growth was 302%. The average annual Net Income (Common) growth rates for DongBang Medical Co Ltd have been 54% over the past three years .
